• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者的经历与家族性高胆固醇血症全球行动呼吁相一致。

Patient experiences align with the familial hypercholesterolemia global call to action.

作者信息

Jones Laney K, Walters Nicole, Brangan Andrew, Ahmed Catherine D, Wilemon Katherine A, Campbell-Salome Gemme, Rahm Alanna K, Gidding Samuel S, Sturm Amy C

机构信息

Genomic Medicine Institute, Geisinger, Danville, PA, United States of America.

Heart and Vascular Institute, Geisinger, Danville, PA, United States of America.

出版信息

Am J Prev Cardiol. 2022 Apr 18;10:100344. doi: 10.1016/j.ajpc.2022.100344. eCollection 2022 Jun.

DOI:10.1016/j.ajpc.2022.100344
PMID:35517872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9061613/
Abstract

OBJECTIVE

To explore alignment of perspectives from individuals and families with familial hypercholesterolemia (FH) to the FH Global Call to Action recommendations.

METHODS

Interviews and focus groups were conducted with individuals and families with FH from multiple U.S. health systems and the Family Heart Foundation community to capture lived experiences and to identify barriers to diagnosis, cascade testing, and treatment. Participant perspectives were examined and classified, according to their alignment to recommendations of the FH Global Call to Action.

RESULTS

A total of 75 lived experiences were analyzed. Participants were majority female, mostly white, older, and well-educated. Participants most frequently mentioned recommendations were family-based care (84%) and screening, testing, & diagnosis (84%), followed by treatment (69%), advocacy (60%), cost & value (59%), awareness (56%), research & registries (43%), and severe & homozygous FH (11%). An average of 4.65 (SD 1.76) recommendations were mentioned.

CONCLUSIONS

The FH Global Call to Action was driven by the persistent unmet needs of those living with FH in receiving a timely diagnosis, appropriate care, and support to prevent early morbidity and mortality. Patient- and family-centric perspectives suggest the FH Global Call to Action captures these concerns. Acting on recommendations, particularly improvements in screening and family-based care, will address patient, and public health, concerns.

摘要

目的

探讨家族性高胆固醇血症(FH)患者及其家庭的观点与《FH全球行动呼吁》建议的一致性。

方法

对来自多个美国医疗系统以及家庭心脏基金会社区的FH患者及其家庭进行访谈和焦点小组讨论,以了解他们的实际生活经历,并确定诊断、级联检测和治疗的障碍。根据参与者的观点与《FH全球行动呼吁》建议的一致性进行检查和分类。

结果

共分析了75个实际生活经历。参与者以女性为主,大多为白人,年龄较大且受教育程度较高。参与者最常提到的建议是家庭式护理(84%)和筛查、检测与诊断(84%),其次是治疗(69%)、宣传(60%)、成本与价值(59%)、认知(56%)、研究与登记(43%)以及重度和纯合子FH(11%)。平均提到4.65条(标准差1.76)建议。

结论

《FH全球行动呼吁》是由FH患者在及时获得诊断、适当护理和支持以预防早期发病和死亡方面持续未得到满足的需求所推动的。以患者和家庭为中心的观点表明,《FH全球行动呼吁》抓住了这些问题。按照建议采取行动,特别是改善筛查和家庭式护理,将解决患者和公共卫生方面的问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474d/9061613/9f2f1a182390/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474d/9061613/f42497e1c87f/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474d/9061613/67793b140e21/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474d/9061613/9f2f1a182390/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474d/9061613/f42497e1c87f/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474d/9061613/67793b140e21/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474d/9061613/9f2f1a182390/gr2.jpg

相似文献

1
Patient experiences align with the familial hypercholesterolemia global call to action.患者的经历与家族性高胆固醇血症全球行动呼吁相一致。
Am J Prev Cardiol. 2022 Apr 18;10:100344. doi: 10.1016/j.ajpc.2022.100344. eCollection 2022 Jun.
2
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action.降低家族性高胆固醇血症的临床和公共卫生负担:全球行动呼吁。
JAMA Cardiol. 2020 Feb 1;5(2):217-229. doi: 10.1001/jamacardio.2019.5173.
3
Low-density lipoprotein apheresis: an evidence-based analysis.低密度脂蛋白单采术:一项基于证据的分析。
Ont Health Technol Assess Ser. 2007;7(5):1-101. Epub 2006 Nov 1.
4
Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.家族性高胆固醇血症基金会 CAscade 筛查以提高对家族性高胆固醇血症的认识和检测的注册研究的基本原理和设计。
Am Heart J. 2014 Mar;167(3):342-349.e17. doi: 10.1016/j.ahj.2013.12.008. Epub 2013 Dec 21.
5
In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members.在儿科家族性高胆固醇血症中,脂蛋白(a)比 LDL-C 更能预测家族成员心血管疾病的早发。
J Clin Lipidol. 2018 Nov-Dec;12(6):1445-1451. doi: 10.1016/j.jacl.2018.07.014. Epub 2018 Jul 31.
6
Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.家族性高胆固醇血症成年患者的纵向低密度脂蛋白胆固醇目标达标与心血管结局:CASCADE FH 登记研究。
Atherosclerosis. 2019 Oct;289:85-93. doi: 10.1016/j.atherosclerosis.2019.08.007. Epub 2019 Aug 19.
7
Genetic Diagnosis of Familial Hypercholesterolemia in Asia.亚洲家族性高胆固醇血症的基因诊断
Front Genet. 2020 Jul 24;11:833. doi: 10.3389/fgene.2020.00833. eCollection 2020.
8
Familial Hypercholesterolemia Identification Algorithm in Patients with Acute Cardiovascular Events in A Large Hospital Electronic Database in Bulgaria: A Call for Implementation.保加利亚一家大型医院电子数据库中急性心血管事件患者的家族性高胆固醇血症识别算法:呼吁实施。
Adv Ther. 2021 May;38(5):2323-2338. doi: 10.1007/s12325-020-01608-3. Epub 2021 Mar 23.
9
Familial Hypercholesterolemia: Global Burden and Approaches.家族性高胆固醇血症:全球负担与方法。
Curr Cardiol Rep. 2021 Sep 4;23(10):151. doi: 10.1007/s11886-021-01565-5.
10
Familial hypercholesterolemia and cardiovascular disease in older individuals.家族性高胆固醇血症与老年人群的心血管疾病
Atherosclerosis. 2021 Feb;318:32-37. doi: 10.1016/j.atherosclerosis.2020.12.012. Epub 2020 Dec 19.

引用本文的文献

1
Living with Elevated Lipoprotein(a) Levels: The Experiences of Patients and Caregivers.脂蛋白(a)水平升高患者的生活经历:患者及照料者的体验
Patient Prefer Adherence. 2025 Feb 21;19:395-405. doi: 10.2147/PPA.S478623. eCollection 2025.
2
Primary care clinician engagement in implementing a machine-learning algorithm for targeted screening of familial hypercholesterolemia.基层医疗临床医生参与实施用于家族性高胆固醇血症靶向筛查的机器学习算法。
Am J Prev Cardiol. 2024 Jul 22;19:100710. doi: 10.1016/j.ajpc.2024.100710. eCollection 2024 Sep.
3
Childhood Screening for Familial Hypercholesterolemia: JACC Review Topic of the Week.

本文引用的文献

1
Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study.用于识别家族性高胆固醇血症的自动筛查方法和家庭沟通方式的可接受性、适宜性和可行性:IMPACT-FH研究的利益相关者参与结果
J Pers Med. 2021 Jun 21;11(6):587. doi: 10.3390/jpm11060587.
2
Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia.开发和优化创新性工具以解决家族性高胆固醇血症漏诊问题:家族性高胆固醇血症的识别方法、患者激活和级联检测。
Circ Genom Precis Med. 2021 Feb;14(1):e003120. doi: 10.1161/CIRCGEN.120.003120. Epub 2021 Jan 22.
3
儿童家族性高胆固醇血症筛查:美国心脏病学会评论专题之周更。
J Am Coll Cardiol. 2023 Oct 10;82(15):1558-1563. doi: 10.1016/j.jacc.2023.07.028.
4
Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID-19 pandemic.COVID-19 大流行期间家族性高胆固醇血症患者心血管管理和预防服务的获取障碍和不足。
Clin Cardiol. 2023 Aug;46(8):831-844. doi: 10.1002/clc.24059. Epub 2023 Jun 1.
5
How Can Implementation Science Improve the Care of Familial Hypercholesterolaemia?如何利用实施科学改善家族性高胆固醇血症的治疗?
Curr Atheroscler Rep. 2023 Apr;25(4):133-143. doi: 10.1007/s11883-023-01090-6. Epub 2023 Feb 20.
Barriers, facilitators, and solutions to familial hypercholesterolemia treatment.家族性高胆固醇血症治疗的障碍、促进因素和解决方案。
PLoS One. 2020 Dec 23;15(12):e0244193. doi: 10.1371/journal.pone.0244193. eCollection 2020.
4
Hui: a partnership in practice in familial hypercholesterolemia.
N Z Med J. 2020 Sep 25;133(1522):63-70.
5
Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care.家族性高胆固醇血症早期诊断与治疗的障碍:改善患者护理的当前观点
Vasc Health Risk Manag. 2020 Jan 9;16:11-25. doi: 10.2147/VHRM.S192401. eCollection 2020.
6
The development of a theory informed behaviour change intervention to improve adherence to dietary and physical activity treatment guidelines in individuals with familial hypercholesterolaemia (FH).旨在提高家族性高胆固醇血症患者饮食和身体活动治疗指南依从性的理论指导行为改变干预措施的制定。
BMC Health Serv Res. 2020 Jan 8;20(1):27. doi: 10.1186/s12913-019-4869-4.
7
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action.降低家族性高胆固醇血症的临床和公共卫生负担:全球行动呼吁。
JAMA Cardiol. 2020 Feb 1;5(2):217-229. doi: 10.1001/jamacardio.2019.5173.
8
"How do we rally around the one who was positive?" Familial uncertainty management in the context of men managing BRCA-related cancer risks.我们如何团结那个阳性患者?男性管理 BRCA 相关癌症风险背景下的家庭不确定性管理。
Soc Sci Med. 2019 Dec;242:112592. doi: 10.1016/j.socscimed.2019.112592. Epub 2019 Oct 11.
9
Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis.杂合子家族性高胆固醇血症治疗依从性的促进因素和阻碍因素:定性证据综合分析。
BMJ Open. 2019 Jul 31;9(7):e030290. doi: 10.1136/bmjopen-2019-030290.
10
Barriers and Facilitators to Genetic Testing for Familial Hypercholesterolemia in the United States: A Review.美国家族性高胆固醇血症基因检测的障碍与促进因素:一项综述
J Pers Med. 2019 Jul 1;9(3):32. doi: 10.3390/jpm9030032.